Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Filings indexed 1,000 across all filing types
Latest filing 2011-05-10 Capital/Financing Update
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
FILED PURSUANT TO RULE 424(B)(3)
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) under the Securities Act of 1933, relating to the resale of shares by selling stockholders. It details the offering of 6,000,000 shares of common stock, the use of proceeds, risk factors, and other information typical of a securities offering document. It is not a financial report, earnings release, or management discussion, but rather a capital markets disclosure document related to share resale and registration. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. The document is substantive and lengthy (15,000 characters), not a brief announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2011-05-10 English
Regulatory Filings 2011
Regulatory Filings
2011-05-09 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effectiveness of a Registration Statement on Form S-3. It is a formal communication related to the registration and offering process, specifically requesting the SEC to declare the registration statement effective earlier than usual. The document does not contain financial statements, audit information, or detailed report content. It is a regulatory filing related to securities registration and compliance, not a financial report or announcement of voting results, management changes, or earnings. Given the short length (1576 characters) and the nature of the content (a formal request to the SEC), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2011-05-02 English
AMENDMENT NO. 1 TO FORM S-3
Regulatory Filings Classification · 95% confidence The document is titled 'Amendment No. 1 to Form S-3' and is a registration statement filed with the SEC under the Securities Act of 1933. It includes detailed information about the securities being registered, the offering, risk factors, and company overview. Form S-3 is a registration statement used for securities offerings, not a financial report or earnings release. The document is a regulatory filing related to capital raising but is not an earnings release or capital update per se. It is a formal SEC filing for registration of securities for resale by selling stockholders. Therefore, the most appropriate classification is 'Regulatory Filings' (RNS), as it is a general regulatory announcement and does not fit into other specific categories like Capital/Financing Update or Earnings Release.
2011-04-25 English
Regulatory Filings 2011
Regulatory Filings
2011-04-20 English
FORM 4
Director's Dealing
2011-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.